Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmacological Reports

• Publication date

  2012-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1734-1140(12)70742-9PMID 22580532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Region‐specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin

  2010cited by this paper
• Levetiracetam: a comprehensive review.

  2010cited by this paper
• Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.

  2010cited by this paper
• Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment?

  2010cited by this paper
• Effect of levetiracetam on hippocampal protein expression and cell proliferation in rats.

  2010cited by this paper
• Levetiracetam for seizures in children with brain tumors and other cancers

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.

  2009cited by this paper
• HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam.

  2008cited by this paper
• Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells

  2008cited by this paper
• Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells.

  2008cited by this paper
• In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor

  2008cited by this paper
• Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.

  2007cited by this paper
• A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

  2007cited by this paper
• Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.

  2007cited by this paper
• Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells

  2007cited by this paper
• Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors

  2007cited by this paper
• Levetiracetam use in critically ill patients

  2007cited by this paper
• Levetiracetam therapy in patients with brain tumour and epilepsy

  2006cited by this paper
• Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

  2006cited by this paper
• The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma.

  2006cited by this paper
• Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies

  2005cited by this paper
• Mammalian cyclin-dependent kinases.

  2005cited by this paper
• Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.

  2005cited by this paper
• Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC

  2005cited by this paper
• The antiepileptic drug levetiracetam selectively modifies kindling‐induced alterations in gene expression in the temporal lobe of rats

  2004cited by this paper
• Human ovarian carcinoma cells: Histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis

  2004influential reference
• Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells

  2004cited by this paper
• Levetiracetam: preliminary experience in patients with primary brain tumours

  2003cited by this paper
• Anti‐tumor mechanisms of valproate: A novel role for an old drug

  2002cited by this paper
• Lysosomal Enzyme-Induced Cell Death in MCF7 and Mammary Gland Cells.

  2001cited by this paper
• Activity and localisation of the lysosomal marker enzymes acid phosphatase, N-acetyl-beta-D-glucosaminidase, and beta-galactosidase in the earthworms Eisenia fetida and E. veneta.

  2000cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

  1994cited by this paper
• Lysosomes in mice mammary tumors treated with cyclophosphamide: Distribution related to course of disease

  1968cited by this paper

• Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives

  2025cites this paper
• Valproic Acid Enhances the Anticancer Effect of L-Ascorbic Acid by Upregulating Sodium-Dependent Vitamin C Transporter 2 in Colorectal Cancer

  2025cites this paper
• Oligoprotective Activity of Levetiracetam Against Glutamate Toxicity: An in vitro Study.

  2024cites this paper
• Study of anticancer effects of platinum levetiracetam and levetiracetam via cancer biomarkers genes expression on HepG2 cell line

  2023cites this paper
• Synthesis, characterization, toxicity and morphology assessments of newly prepared microemulsion systems for delivery of valproic acid

  2021cites this paper
• Levetiracetam promoted rat embryonic neurogenesis via NMDA receptor-mediated mechanism in vitro.

  2021cites this paper
• Effect of valproic acid on Expression of Bim gene and viability of ovarian cancer cell line A2780

  2020cites this paper
• Bipolar Disorder Treatments and Ovarian Cancer: A Systematic Review

  2020cites this paper
• A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects

  2020cites this paper
• Valproic Acid Inhibits NA-K-2CL Cotransporter RNA Expression in Male But Not in Female Rat Thymocytes

  2019cites this paper
• The effect of sodium valproate on differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in two-dimensional culture and fibrin scaffold conditions

  2019cites this paper
• α-Glucosidase inhibitory activities, functional properties, and safety of green tea polysaccharides as a potential source of dietary supplement

  2018cites this paper
• Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies

  2018cites this paper
• Antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of Psidium guineense Sw. and spathulenol.

  2018cites this paper
• Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes

  2017cites this paper
• Biotransformation of abietic acid by fungi and biological evaluation of its metabolites

  2017cites this paper
• اثر والپروئیک اسید بر بیان ژن Bim و زیستپذیری سلولهای سرطان تخمدان رده A2780

  2017cites this paper
• Cytotoxic, Antiproliferative and Apoptotic Effects of Perillyl Alcohol and Its Biotransformation Metabolite on A549 and HepG2 Cancer Cell Lines.

  2017cites this paper
• In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells

  2017cites this paper
• Valproic Acid as a Promising Co-Treatment With Paclitaxel and Doxorubicin in Different Ovarian Carcinoma Cell Lines

  2016cites this paper
• GENOTOXIC AND MUTAGENIC STUDIES OF THE ANTIEPILEPTIC DRUG LEVETIRACETAM IN PREGNANT RATS AND THEIR FETUSES

  2016cites this paper
• Sodium valproate effect on the structure of rat glandule thymus: Gender-related differences.

  2015cites this paper
• Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.

  2015cites this paper
• Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.

  2014influential citation
• Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3

  2012influential citation
• Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression

  2012cites this paper
• Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3

  2012influential citation